116 related articles for article (PubMed ID: 20225688)
1. [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
Rosenborg S
Lakartidningen; 2010 Jan 20-26; 107(3):116-7. PubMed ID: 20225688
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
Karie S; Launay-Vacher V; Janus N; Izzedine H; Deray G
Nephrol Dial Transplant; 2006 Dec; 21(12):3606-8. PubMed ID: 16799172
[No Abstract] [Full Text] [Related]
3. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
Greener M
Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
[No Abstract] [Full Text] [Related]
4. Oseltamivir dosing in children undergoing hemodialysis.
Schreuder MF; van der Flier M; Knops NB; Koster-Kamphuis L; Brüggemann RJ
Clin Infect Dis; 2010 May; 50(10):1427-8. PubMed ID: 20397934
[No Abstract] [Full Text] [Related]
5. Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
Brewster M; Smith JR; Dutkowski R; Robson R
Vaccine; 2006 Nov; 24(44-46):6660-3. PubMed ID: 16797800
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Robson R; Buttimore A; Lynn K; Brewster M; Ward P
Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169
[TBL] [Abstract][Full Text] [Related]
7. Tamiflu: what dermatologists need to know.
Bergstrom KG
J Drugs Dermatol; 2010 Jan; 9(1):76-8. PubMed ID: 20120431
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis.
Patel K; Rayner CR; Giraudon M; Kamal MA; Morcos PN; Robson R; Kirkpatrick CM
Br J Clin Pharmacol; 2015 Apr; 79(4):624-35. PubMed ID: 25289522
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy and prophylaxis for influenza in children.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
[TBL] [Abstract][Full Text] [Related]
10. [Tamiflu, suicides and seasonal influenza].
Nau JY
Rev Med Suisse; 2007 Apr; 3(105):895. PubMed ID: 17514933
[No Abstract] [Full Text] [Related]
11. Neuropsychiatric concerns related to influenza treatment.
Vantine M; Falahee ML; Vallerand AH
Nurse Pract; 2009 Feb; 34(2):40-4. PubMed ID: 19155886
[No Abstract] [Full Text] [Related]
12. A caution about giving Tamiflu to children.
Child Health Alert; 2009 Nov; 27():4-5. PubMed ID: 20050174
[No Abstract] [Full Text] [Related]
13. Lack of unwanted effects of oseltamivir carboxylate in juvenile rats after subcutaneous administration.
Freichel C; Breidenbach A; Gand L; Toot J; Weiser T; Körner A; Singer T; Prinssen E; Hoffmann G
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):551-3. PubMed ID: 22145997
[No Abstract] [Full Text] [Related]
14. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
[TBL] [Abstract][Full Text] [Related]
15. Antiviral drugs for influenza.
Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
[No Abstract] [Full Text] [Related]
16. Oseltamivir and its active metabolite cross the placenta at significant levels.
Meijer WJ; Bruinse HW; van den Broek MP; Kromdijk W; Wensing AM
Clin Infect Dis; 2012 Jun; 54(11):1676-7. PubMed ID: 22460968
[No Abstract] [Full Text] [Related]
17. A concise and flexible synthesis of the potent anti-influenza agents tamiflu and tamiphosphor.
Shie JJ; Fang JM; Wong CH
Angew Chem Int Ed Engl; 2008; 47(31):5788-91. PubMed ID: 18613158
[No Abstract] [Full Text] [Related]
18. Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
Ogihara T; Kano T; Wagatsuma T; Wada S; Yabuuchi H; Enomoto S; Morimoto K; Shirasaka Y; Kobayashi S; Tamai I
Drug Metab Dispos; 2009 Aug; 37(8):1676-81. PubMed ID: 19439487
[TBL] [Abstract][Full Text] [Related]
19. Tamiflu and neuropsychiatric disturbance in adolescents.
Maxwell SR
BMJ; 2007 Jun; 334(7606):1232-3. PubMed ID: 17569896
[TBL] [Abstract][Full Text] [Related]
20. Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk.
Eschenauer GA; Lam SW
Intensive Care Med; 2011 Feb; 37(2):371. PubMed ID: 21103860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
